RxDoctor Payments Data

Alexander Bradley, MD

Adult Reconstructive Orthopaedic Surgery · Dublin, CANPI 1194259077

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (33.3%), education and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Think Surgical, Inc. at 33.4% of the total. Reporting peaked in 2023 at $23,198 and has fallen 97.1% since, to $668 in 2025.

$33,050in general payments, 2019–2025

Across 124 payments — averaging $266.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Think Surgical, Inc.$11K
  • Smith+Nephew$9K
  • Stryker$4K
  • Zimmer Biomet$3K
  • Encore Medical, LP$3K
  • Medical Device Business Services, Inc.$754
  • plus $1K from 7 others

What the payments were for

  • Consulting fees$11,00033%
  • Speaking & faculty fees$1,5005%
  • Travel & lodging$4,30013%
  • Food & beverage$6,65620%
  • Education$9,59529%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,050 in reported general payments places this provider in the 65th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$476,836
Medicare patients
577
Services billed
4,478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib192$13,650
Diclofenac Sodium201$3,798
Pantoprazole Sodium193$2,072
Ondansetron OdtOndansetron143$1,423
Cyclobenzaprine Hcl138$1,394
Pregabalin73$1,298
Tranexamic Acid119$1,057
Oxycodone Hcl143$813
Tramadol Hcl182$633
Cefadroxil40$353
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$330
Meloxicam95$275
Amoxicillin21$21

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Dublin

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →